Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
Identifieur interne : 000963 ( PubMed/Corpus ); précédent : 000962; suivant : 000964Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
Auteurs : Jeanne M. Sisk ; Matthew B. Frieman ; Carolyn E. MachamerSource :
- The Journal of general virology [ 1465-2099 ] ; 2018.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (pharmacology), Benzamides (pharmacology), Cell Membrane, Chlorocebus aethiops, Endosomes (virology), Imatinib Mesylate (pharmacology), Infectious bronchitis virus (genetics), Infectious bronchitis virus (metabolism), Protein Kinase Inhibitors (pharmacology), Proto-Oncogene Proteins c-abl (antagonists & inhibitors), Pyrimidines (pharmacology), Spike Glycoprotein, Coronavirus (genetics), Spike Glycoprotein, Coronavirus (metabolism), Vero Cells, Virus Internalization, Virus Replication.
- MESH :
- chemical , antagonists & inhibitors : Proto-Oncogene Proteins c-abl.
- chemical , genetics : Spike Glycoprotein, Coronavirus.
- chemical , metabolism : Spike Glycoprotein, Coronavirus.
- chemical , pharmacology : Antiviral Agents, Benzamides, Imatinib Mesylate, Protein Kinase Inhibitors, Pyrimidines.
- genetics : Infectious bronchitis virus.
- metabolism : Infectious bronchitis virus.
- virology : Endosomes.
- Animals, Cell Membrane, Chlorocebus aethiops, Vero Cells, Virus Internalization, Virus Replication.
Abstract
Enveloped viruses gain entry into host cells by fusing with cellular membranes, a step that is required for virus replication. Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and infectious bronchitis virus (IBV), fuse at the plasma membrane or use receptor-mediated endocytosis and fuse with endosomes, depending on the cell or tissue type. The virus spike (S) protein mediates fusion with the host cell membrane. We have shown previously that an Abelson (Abl) kinase inhibitor, imatinib, significantly reduces SARS-CoV and MERS-CoV viral titres and prevents endosomal entry by HIV SARS S and MERS S pseudotyped virions. SARS-CoV and MERS-CoV are classified as BSL-3 viruses, which makes experimentation into the cellular mechanisms involved in infection more challenging. Here, we use IBV, a BSL-2 virus, as a model for studying the role of Abl kinase activity during coronavirus infection. We found that imatinib and two specific Abl kinase inhibitors, GNF2 and GNF5, reduce IBV titres by blocking the first round of virus infection. Additionally, all three drugs prevented IBV S-induced syncytia formation prior to the hemifusion step. Our results indicate that membrane fusion (both virus-cell and cell-cell) is blocked in the presence of Abl kinase inhibitors. Studying the effects of Abl kinase inhibitors on IBV will be useful in identifying the host cell pathways required for coronavirus infection. This will provide an insight into possible therapeutic targets to treat infections by current as well as newly emerging coronaviruses.
DOI: 10.1099/jgv.0.001047
PubMed: 29557770
Links to Exploration step
pubmed:29557770Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.</title><author><name sortKey="Sisk, Jeanne M" sort="Sisk, Jeanne M" uniqKey="Sisk J" first="Jeanne M" last="Sisk">Jeanne M. Sisk</name><affiliation><nlm:affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Frieman, Matthew B" sort="Frieman, Matthew B" uniqKey="Frieman M" first="Matthew B" last="Frieman">Matthew B. Frieman</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Machamer, Carolyn E" sort="Machamer, Carolyn E" uniqKey="Machamer C" first="Carolyn E" last="Machamer">Carolyn E. Machamer</name><affiliation><nlm:affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29557770</idno><idno type="pmid">29557770</idno><idno type="doi">10.1099/jgv.0.001047</idno><idno type="wicri:Area/PubMed/Corpus">000963</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000963</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.</title><author><name sortKey="Sisk, Jeanne M" sort="Sisk, Jeanne M" uniqKey="Sisk J" first="Jeanne M" last="Sisk">Jeanne M. Sisk</name><affiliation><nlm:affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Frieman, Matthew B" sort="Frieman, Matthew B" uniqKey="Frieman M" first="Matthew B" last="Frieman">Matthew B. Frieman</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Machamer, Carolyn E" sort="Machamer, Carolyn E" uniqKey="Machamer C" first="Carolyn E" last="Machamer">Carolyn E. Machamer</name><affiliation><nlm:affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The Journal of general virology</title><idno type="eISSN">1465-2099</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (pharmacology)</term><term>Benzamides (pharmacology)</term><term>Cell Membrane</term><term>Chlorocebus aethiops</term><term>Endosomes (virology)</term><term>Imatinib Mesylate (pharmacology)</term><term>Infectious bronchitis virus (genetics)</term><term>Infectious bronchitis virus (metabolism)</term><term>Protein Kinase Inhibitors (pharmacology)</term><term>Proto-Oncogene Proteins c-abl (antagonists & inhibitors)</term><term>Pyrimidines (pharmacology)</term><term>Spike Glycoprotein, Coronavirus (genetics)</term><term>Spike Glycoprotein, Coronavirus (metabolism)</term><term>Vero Cells</term><term>Virus Internalization</term><term>Virus Replication</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Proto-Oncogene Proteins c-abl</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Spike Glycoprotein, Coronavirus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Spike Glycoprotein, Coronavirus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term><term>Benzamides</term><term>Imatinib Mesylate</term><term>Protein Kinase Inhibitors</term><term>Pyrimidines</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Infectious bronchitis virus</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Infectious bronchitis virus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Endosomes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cell Membrane</term><term>Chlorocebus aethiops</term><term>Vero Cells</term><term>Virus Internalization</term><term>Virus Replication</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Enveloped viruses gain entry into host cells by fusing with cellular membranes, a step that is required for virus replication. Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and infectious bronchitis virus (IBV), fuse at the plasma membrane or use receptor-mediated endocytosis and fuse with endosomes, depending on the cell or tissue type. The virus spike (S) protein mediates fusion with the host cell membrane. We have shown previously that an Abelson (Abl) kinase inhibitor, imatinib, significantly reduces SARS-CoV and MERS-CoV viral titres and prevents endosomal entry by HIV SARS S and MERS S pseudotyped virions. SARS-CoV and MERS-CoV are classified as BSL-3 viruses, which makes experimentation into the cellular mechanisms involved in infection more challenging. Here, we use IBV, a BSL-2 virus, as a model for studying the role of Abl kinase activity during coronavirus infection. We found that imatinib and two specific Abl kinase inhibitors, GNF2 and GNF5, reduce IBV titres by blocking the first round of virus infection. Additionally, all three drugs prevented IBV S-induced syncytia formation prior to the hemifusion step. Our results indicate that membrane fusion (both virus-cell and cell-cell) is blocked in the presence of Abl kinase inhibitors. Studying the effects of Abl kinase inhibitors on IBV will be useful in identifying the host cell pathways required for coronavirus infection. This will provide an insight into possible therapeutic targets to treat infections by current as well as newly emerging coronaviruses.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29557770</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-2099</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>The Journal of general virology</Title><ISOAbbreviation>J. Gen. Virol.</ISOAbbreviation></Journal><ArticleTitle>Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.</ArticleTitle><Pagination><MedlinePgn>619-630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1099/jgv.0.001047</ELocationID><Abstract><AbstractText>Enveloped viruses gain entry into host cells by fusing with cellular membranes, a step that is required for virus replication. Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and infectious bronchitis virus (IBV), fuse at the plasma membrane or use receptor-mediated endocytosis and fuse with endosomes, depending on the cell or tissue type. The virus spike (S) protein mediates fusion with the host cell membrane. We have shown previously that an Abelson (Abl) kinase inhibitor, imatinib, significantly reduces SARS-CoV and MERS-CoV viral titres and prevents endosomal entry by HIV SARS S and MERS S pseudotyped virions. SARS-CoV and MERS-CoV are classified as BSL-3 viruses, which makes experimentation into the cellular mechanisms involved in infection more challenging. Here, we use IBV, a BSL-2 virus, as a model for studying the role of Abl kinase activity during coronavirus infection. We found that imatinib and two specific Abl kinase inhibitors, GNF2 and GNF5, reduce IBV titres by blocking the first round of virus infection. Additionally, all three drugs prevented IBV S-induced syncytia formation prior to the hemifusion step. Our results indicate that membrane fusion (both virus-cell and cell-cell) is blocked in the presence of Abl kinase inhibitors. Studying the effects of Abl kinase inhibitors on IBV will be useful in identifying the host cell pathways required for coronavirus infection. This will provide an insight into possible therapeutic targets to treat infections by current as well as newly emerging coronaviruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sisk</LastName><ForeName>Jeanne M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frieman</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machamer</LastName><ForeName>Carolyn E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 AI118303</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI095569</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Virol</MedlineTA><NlmUniqueID>0077340</NlmUniqueID><ISSNLinking>0022-1317</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508526">GNF-2 compound</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000603591">N-(2-hydroxyethyl)-3-(6-((4-(trifluoromethoxy)phenyl)amino)-4-pyrimidinyl)benzamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>8A1O1M485B</RegistryNumber><NameOfSubstance UI="D000068877">Imatinib Mesylate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D016315">Proto-Oncogene Proteins c-abl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068877" MajorTopicYN="N">Imatinib Mesylate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016315" MajorTopicYN="N">Proto-Oncogene Proteins c-abl</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Abl kinase</Keyword><Keyword MajorTopicYN="Y">Abl1</Keyword><Keyword MajorTopicYN="Y">Abl2</Keyword><Keyword MajorTopicYN="Y">GNF2</Keyword><Keyword MajorTopicYN="Y">GNF5</Keyword><Keyword MajorTopicYN="Y">IBV</Keyword><Keyword MajorTopicYN="Y">MERS-CoV</Keyword><Keyword MajorTopicYN="Y">SARS-CoV</Keyword><Keyword MajorTopicYN="Y">cell-cell fusion</Keyword><Keyword MajorTopicYN="Y">coronavirus</Keyword><Keyword MajorTopicYN="Y">imatinib</Keyword><Keyword MajorTopicYN="Y">virus-cell fusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29557770</ArticleId><ArticleId IdType="doi">10.1099/jgv.0.001047</ArticleId><ArticleId IdType="pmc">PMC6537626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 2000 Sep 15;289(5486):1938-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10988075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2001 Jul 20;276(29):27104-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11309382</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2002 Aug 1;62(15):4236-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12154025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2003 Sep;23(18):6385-95</Citation><ArticleIdList><ArticleId IdType="pubmed">12944467</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cell Biol. 2004 Jan;14(1):36-44</Citation><ArticleIdList><ArticleId IdType="pubmed">14729179</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15010527</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Jun;78(11):5913-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15140989</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Microbiol. 2005 Apr;13(4):181-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15817388</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Nov;79(21):13209-17</Citation><ArticleIdList><ArticleId IdType="pubmed">16227244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2006 Jan 13;124(1):119-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16413486</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Microbiol. 2006 Feb;8(2):233-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16441434</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Mar;81(5):2418-28</Citation><ArticleIdList><ArticleId IdType="pubmed">17166901</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2007 May 10;361(2):304-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17210170</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2008 Jul 1;112(1):111-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18305217</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 2009 May 4;185(3):503-19</Citation><ArticleIdList><ArticleId IdType="pubmed">19414610</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 2009 Oct 1;122(Pt 19):3441-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19759284</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Feb;84(4):1891-901</Citation><ArticleIdList><ArticleId IdType="pubmed">20007283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Jan 28;463(7280):501-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20072125</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2010 Jun 17;6(6):e1000956</Citation><ArticleIdList><ArticleId IdType="pubmed">20585556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2010 Sep 14;3(139):re6</Citation><ArticleIdList><ArticleId IdType="pubmed">20841568</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2010 Dec 17;285(51):40201-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20937825</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Jan;85(1):21-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20962097</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Rev Cell Mol Biol. 2011;286:271-300</Citation><ArticleIdList><ArticleId IdType="pubmed">21199784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2011 Mar 1;71(5):1730-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21257711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2011 Jun;9(6):427-39</Citation><ArticleIdList><ArticleId IdType="pubmed">21522191</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Sep;85(17):8903-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21697468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2011 Aug;121(8):3244-57</Citation><ArticleIdList><ArticleId IdType="pubmed">21765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2012 Feb 29;4(123):123ra24</Citation><ArticleIdList><ArticleId IdType="pubmed">22378924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2012 Jul 17;5(233):ra51</Citation><ArticleIdList><ArticleId IdType="pubmed">22810897</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 2012 Aug 21;51(33):6644-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22849492</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cancer. 2012 May;3(5-6):447-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23226582</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2013 Jan 30;33(5):1846-57</Citation><ArticleIdList><ArticleId IdType="pubmed">23365224</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Apr 19;340(6130):359-63</Citation><ArticleIdList><ArticleId IdType="pubmed">23470732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2013 Apr 23;6(272):re2</Citation><ArticleIdList><ArticleId IdType="pubmed">23612709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2013 Aug;13(8):559-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23842646</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2013 Nov 6;177(2):127-37</Citation><ArticleIdList><ArticleId IdType="pubmed">24041648</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuromolecular Med. 2014 Jun;16(2):217-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24522549</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Adh Migr. 2014;8(3):191-204</Citation><ArticleIdList><ArticleId IdType="pubmed">24714644</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24841273</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25288733</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Nov 06;10(11):e1004502</Citation><ArticleIdList><ArticleId IdType="pubmed">25375324</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2015 Apr 16;202:120-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25445340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2015 Feb 13;290(7):4038-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25540195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Mar;89(5):2931-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25552710</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 2015 Jun;32:162-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25989064</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Aug;89(16):8162-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26018170</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2014 Dec;3(12):e84</Citation><ArticleIdList><ArticleId IdType="pubmed">26038505</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2015 Sep 4;290(36):21857-64</Citation><ArticleIdList><ArticleId IdType="pubmed">26203192</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 2016 Jan 1;129(1):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26729027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Cell. 2016 Aug 15;27(16):2613-31</Citation><ArticleIdList><ArticleId IdType="pubmed">27385341</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2016 Sep 12;90(19):8924-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27466418</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1973 Jun 1;243(5405):290-3</Citation><ArticleIdList><ArticleId IdType="pubmed">4126434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Nov 17-23;306(5940):239-42</Citation><ArticleIdList><ArticleId IdType="pubmed">6316147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Nov 17-23;306(5940):277-80</Citation><ArticleIdList><ArticleId IdType="pubmed">6580527</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 1996 Jan 1;56(1):100-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8548747</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 1995;140(12):2201-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8572941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Cell. 1997 Nov;8(11):2233-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9362065</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 1998 Dec;21(6):1259-72</Citation><ArticleIdList><ArticleId IdType="pubmed">9883720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000963 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000963 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:29557770
|texte= Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:29557770" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |